A. Rum

Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST)

M. Gangitano, F. Ferreri, M. Tombini, 2022, Seizure.

Adjunctive Brivaracetam in Older Patients with Focal Seizures: Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)

M. Gangitano, F. Ferreri, M. Tombini, 2022, Drugs & Aging.

Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST)

M. Gangitano, F. Ferreri, M. Tombini, 2021, CNS Drugs.

Neuroacanthocytosis associated with a defect of the 4.1R membrane protein

P. Calabresi, G. Bernardi, A. Pisani, 2007, BMC neurology.

Acanthocytosis as a predisposing factor for non-ketotic hyperglycaemia induced chorea-ballism

P. Calabresi, G. Bernardi, A. Pisani, 2005, Journal of Neurology, Neurosurgery & Psychiatry.

Brivaracetam as Early Add-On Treatment in Patients with Focal Seizures: A Retrospective, Multicenter, Real-World Study

M. Gangitano, F. Ferreri, M. Tombini, 2022, Neurology and Therapy.

Intravenous brivaracetam in status epilepticus: A multicentric retrospective study in Italy

A. Vaudano, E. Bartolini, S. Meletti, 2021, Seizure.